A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Clinical trial NCT05349643 · COMPLETED

Trial details

NCT number: NCT05349643
Sponsor: AmMax Bio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pigmented Villonodular Synovitis TGCT Tenosynovial Giant Cell Tumor

Start date: 2023-01-26
Primary completion: 2024-06-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.